Stockpolly
Search
Delisting risk
TRAW · NASDAQ · Biotechnology

Traws Pharma (TRAW)

Develops oral antivirals for influenza and COVID-19.

$0.5800
Pre-market+0.01 (+1.79%)
At close$0.5698(−3.42%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions27 holders · as of Mar 31, 202623.89%3.62M shares
Insiders10 holders · as of Apr 8, 20264.61%698.9K shares
Otherremainder71.50%10.83M shares

15.15M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Perceptive Advisors LLCInstitution
6.47%979,81513Gfiled May 15, 2026 ↗
Adage Capital Partners GP, L.L.C.Institution
4.82%730,00013Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution
4.48%678,14213Fas of Mar 31, 2026
Orbimed Advisors LLCInstitution
4.00%605,53113Fas of Mar 31, 2026
Squadron Capital Management LLCInstitution
3.38%511,71413Fas of Mar 31, 2026
Dauntless Investment Group, LLCInstitution
2.75%416,99813Fas of Mar 31, 2026
Boothbay Fund Management, LLCInstitution
1.28%194,53613Fas of Mar 31, 2026
Iain D. DukesInsiderdirector, officer: Chief Executive Officer
1.13%171,130Form 4filed Dec 16, 2025 ↗
Adar1 Capital Management, LLCInstitution
1.02%154,09813Fas of Mar 31, 2026
Nikolay SavchukInsiderdirector, officer: Chief Operating Officer
0.99%150,606Form 4filed Dec 16, 2025 ↗
Charles David PauzaInsiderofficer: Chief Science Officer Virology
0.77%115,971Form 4filed Dec 16, 2025 ↗
Robert RedfieldInsiderofficer: Chief Medical Officer
0.75%113,919Form 4filed Dec 16, 2025 ↗
Werner CautreelsInsiderdirector
0.72%109,222Form 4filed Dec 16, 2025 ↗
Geode Capital Management, LLCInstitution
0.51%77,10313Fas of Mar 31, 2026
Palumbo Wealth Management LLCInstitution
0.40%61,17513Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.36%55,19313Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.21%31,80413Fas of Mar 31, 2026
State Street CorpInstitution
0.17%25,80213Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.14%21,24113Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution
0.13%19,24413Fas of Mar 31, 2026
Charles Nolan ParkerInsiderofficer: Chief Financial Officer
0.10%15,393Form 4filed Apr 8, 2026 ↗
LYNX1 Capital Management LPInstitution
0.10%15,07813Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.07%9,95613Fas of Mar 31, 2026
Mary Teresa ShoemakerInsiderdirector
0.04%6,292Form 4filed Dec 16, 2025 ↗
Jack E. StoverInsiderdirector
0.04%6,165Form 4filed Dec 16, 2025 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

27 holders · 3.62M shares · 13 new positions · 15 increased · 4 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
Adage Capital Partners GP, L.L.C.730.0K4.82%0May 15, 2026
Ikarian Capital, LLC678.1K4.48%0May 15, 2026
Orbimed Advisors LLC605.5K4.00%0May 15, 2026
Squadron Capital Management LLC511.7K3.38%−201.8KMay 15, 2026
Dauntless Investment Group, LLC417.0K2.75%+417.0KnewMay 14, 2026
Boothbay Fund Management, LLC194.5K1.28%0May 15, 2026
Adar1 Capital Management, LLC154.1K1.02%−333May 18, 2026
Geode Capital Management, LLC77.1K0.51%+15.5KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
OrbiMed Advisors LLCincl. OrbiMed Capital GP VIII LLC19.90%602.0K13DSep 23, 2024 ↗
Ikarian Capital, LLC9.99%812.5K13GFeb 17, 2026 ↗
Sirenia Capital Management LP9.90%6.57M13GAug 14, 2026 ↗
Alyeska Investment Group, L.P.9.90%302.3K13GFeb 14, 2025 ↗
Adage Capital Management, L.P.9.14%730.0K13GFeb 12, 2026 ↗
Chernett Jorey6.80%543.3K13GJan 16, 2026 ↗
Squadron Master Fund LP6.40%511.7K13GMay 15, 2026 ↗
Perceptive Advisors LLC6.10%979.8K13GMay 15, 2026 ↗

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 16, 2026
Orbimed Advisors LLC10 percent owner
Purchase · 4 lots3,586,374$1.674,191,895

CongressHouse and Senate disclosures

Not reported.